Zoetis Receives FDA EUA for Simparica Trio in Dogs
PARSIPPANY, N.J., August 13, 2026 Zoetis Inc. announced that the U.S. Food and Drug Administration has issued an Emergency...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
PARSIPPANY, N.J., August 13, 2026 Zoetis Inc. announced that the U.S. Food and Drug Administration has issued an Emergency...
Johns Creek, Georgia, August, USA 10, 2026 Boehringer Ingelheim Animal Health is highlighting the next generation of veterinary researchers...
INDIANAPOLIS, June 15, 2026 Elanco Animal Health Incorporated has announced that the U.S. Department of Agriculture (USDA) has approved...
OVERLAND PARK, Kan., and BOULDER, Colo., May 12, 2026 Hill’s Pet Nutrition and Bond Pet Foods have announced a...
RALEIGH, NC, March 30, 2026 The AKC Canine Health Foundation (CHF) has announced a strategic collaboration with the educational...
